The Mesothelioma Guide Blog

The COVID‑19 pandemic has been a challenge for cancer patients. Many are anxious about going to a hospital for in‑person appointments. For some, such as people with thoracic...

Encouraging results from a clinical trial at MD Anderson Cancer Center raised an important question. After approval for pleural mesothelioma, can two immunotherapy drugs work for...

Hot chemotherapy seems to supplement radical surgery quite well, especially for peritoneal mesothelioma. For pleural mesothelioma, the feelings are divided. Numerous reports...

Peritoneal mesothelioma, a cancer of the abdominal lining, often deceives doctors, patients and more of its presence. The main reason for this is the signs of peritoneal...

Using checkpoint inhibitors is the latest hot‑button topic among oncologists and cancer specialists. Mesothelioma is no different. Most use immune checkpoint inhibitors, a form...

With bankruptcy in mind, Johnson & Johnson took another big shot in its fight against mesothelioma claims. According to a report from Bloomberg Law, a California appellate...

Is the internet trustworthy? That’s a loaded question, one without a clear‑cut answer. Zoom in a little closer: Is the internet trustworthy for researching cancer? It’s a...

The top mesothelioma cancer centers in the world offer experienced staff, plenty of treatment options and additional support resources. There’s a subset within the segment of...

The first preference for treating mesothelioma is surgery. If you can remove the cancerous tumors in bulk, quickly, then the chances of a long and healthy life increase...

The U.S. Food and Drug Administration (FDA) granted ONCOFID‑P “orphan drug status” for treating malignant mesothelioma. ONCOFID‑P is a combination of paclitaxel and...